3 July 2023

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

Total Voting Rights

Cambridge Cognition (AIM: COG), which develops and markets digital solutions to assess brain health, announces that pursuant to its block admission facility, details of which were announced on 21 March 2023, it has recently issued 37,444 new ordinary shares in the Company in satisfaction of the exercise of employee share options.  Accordingly, as at 30 June 2023 the Company has 34,852,833 ordinary shares in issue.

There are no shares held in treasury therefore the total number of voting rights in the Company is 34,852,833. This figure may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in Cambridge Cognition under the FCA's Disclosure and Transparency Rules.

The Company intends to notify on a monthly basis when there are changes to the issued share capital of the Company, and these monthly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company, under the FCA's Disclosure Guidance and Transparency Rules.

Enquiries: